Drawing for CUTECELL

USPTO serial 87409880

CUTECELL

Reviewed by CopyMark Law Group

Reg. 6789726Status 700Registered
Filing date
Status date
Registration date
Jul 12, 2022
Examiner
HOWARD, PARKER WALDRIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CUTECELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay Kaplan

Lindsay Kaplan L. Kaplan LawPO Box 4062Kingston, NY 12402United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary useACTIVESep 1, 2020
010Medical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; suture material; cases fitted for medical instruments; receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogelsACTIVESep 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Sep 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 12, 2022EXPTEXPARTE APPEAL TERMINATED—
Jul 12, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 12, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 3, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 31, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 31, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 26, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 4, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Apr 5, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 28, 2022GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Jan 28, 2022GECDACTION DENYING REQ FOR RECON E-MAILED—
Jan 28, 2022CNCFSU - ACTION CONTINUING FINAL - WRITTEN—
Jan 18, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2022EXPIEX PARTE APPEAL-INSTITUTED—
Jan 11, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 11, 2022EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jan 10, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 9, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 9, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 9, 2021CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2021ALIEASSIGNED TO LIE—
Mar 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 17, 2020IUAFUSE AMENDMENT FILED—
Sep 17, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 20, 2020EX5GSOU EXTENSION 5 GRANTED—
Apr 14, 2020EXT5SOU EXTENSION 5 FILED—
Apr 14, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 14, 2019EX4GSOU EXTENSION 4 GRANTED—
Oct 14, 2019EXT4SOU EXTENSION 4 FILED—
Oct 14, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 23, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 22, 2019EX3GSOU EXTENSION 3 GRANTED—
Aug 14, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Aug 14, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 14, 2019PETGPETITION TO REVIVE-GRANTED—
Aug 14, 2019PROATEAS PETITION TO REVIVE RECEIVED—
May 20, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 17, 2019EXT3SOU EXTENSION 3 FILED—
Mar 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 12, 2019EX2GSOU EXTENSION 2 GRANTED—
Mar 8, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 17, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Jan 16, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 16, 2019PETGPETITION TO REVIVE-GRANTED—
Jan 16, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Nov 19, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 19, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 17, 2018EXT2SOU EXTENSION 2 FILED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 24, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 22, 2018EX1GSOU EXTENSION 1 GRANTED—
Feb 22, 2018EXT1SOU EXTENSION 1 FILED—
Feb 22, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 17, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 22, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 17, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2017DOCKASSIGNED TO EXAMINER—
Apr 21, 2017MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 20, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 17, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance